We are live on
!
Find out more
PCTC
Perkins Coie Trust Company Portfolio holdings
AUM
$603M
1-Year Est. Return
23.96%
This Fund
S&P 500
This Quarter
Est. Return
-3.8%
1 Year Est. Return
+23.96%
3 Year Est. Return
+70.83%
5 Year Est. Return
+78.43%
10 Year Est. Return
+317.5%
AUM
$354M
AUM Growth
+$2.29M
(+0.65%)
Cap. Flow
+$18.8M
Cap. Flow
% of AUM
5.3%
Top 10 Holdings %
Top 10 Hldgs %
42.58%
Holding
615
New
388
Increased
118
Reduced
43
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$8.91M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$2.6M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$1.35M |
| 4 |
D.R. Horton
DHI
|
+$865K |
| 5 |
JPMorgan Chase
JPM
|
+$857K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$2.95M |
| 2 |
Apple
AAPL
|
+$853K |
| 3 |
Stryker
SYK
|
+$696K |
| 4 |
Danaher
DHR
|
+$576K |
| 5 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
+$531K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.17% |
| 2 | Financials | 9.56% |
| 3 | Healthcare | 9.16% |
| 4 | Industrials | 8.06% |
| 5 | Consumer Staples | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Marvell Technology
MRVL
$187B
| $3.63K | ﹤0.01% |
+67
| New | +$3.96K |
|
302
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.5B
| $3.57K | ﹤0.01% |
+47
| New | +$3.66K |
|
303
iShares TIPS Bond ETF
TIP
$14.7B
| $3.53K | ﹤0.01% |
+34
| New | +$3.6K |
|
304
Illinois Tool Works
ITW
$83.9B
| $3.45K | ﹤0.01% |
+15
| New | +$3.66K |
|
305
Cigna
CI
$73.6B
| $3.43K | ﹤0.01% |
+12
| New | +$3.42K |
|
306
General Motors
GM
$77.2B
| $3.43K | ﹤0.01% |
+104
| New | +$3.69K |
|
307
iShares MSCI Pacific ex Japan ETF
EPP
$2.26B
| $3.38K | ﹤0.01% |
85
| – | – |
|
308
Estee Lauder
EL
$31.5B
| $3.32K | ﹤0.01% |
23
| – | – |
|
309
Regeneron Pharmaceuticals
REGN
$83.2B
| $3.29K | ﹤0.01% |
+4
| New | +$3.14K |
|
310
Ford
F
$55.8B
| $3.28K | ﹤0.01% |
264
+64
| +32% | +$831 |
|
311
Bio-Rad Laboratories Class A
BIO
$9.48B
| $3.23K | ﹤0.01% |
+9
| New | +$3.47K |
|
312
iShares MSCI Switzerland ETF
EWL
$2.24B
| $3.18K | ﹤0.01% |
73
-29
| -28% | -$1.33K |
|
313
Hilton Worldwide
HLT
$70B
| $3.15K | ﹤0.01% |
+21
| New | +$3.17K |
|
314
Gartner
IT
$12.2B
| $3.09K | ﹤0.01% |
+9
| New | +$3.14K |
|
315
Kenvue
KVUE
$36.5B
| $3.07K | ﹤0.01% |
+153
| New | +$3.54K |
|
316
Ross Stores
ROST
$81.7B
| $2.93K | ﹤0.01% |
+26
| New | +$2.98K |
|
317
Aon
AON
$75.7B
| $2.92K | ﹤0.01% |
+9
| New | +$2.98K |
|
318
American Express
AXP
$229B
| $2.83K | ﹤0.01% |
19
-131
| -87% | -$21.4K |
|
319
United Rentals
URI
$70.8B
| $2.67K | ﹤0.01% |
+6
| New | +$2.75K |
|
320
TJX Companies
TJX
$175B
| $2.67K | ﹤0.01% |
+30
| New | +$2.64K |
|
321
AstraZeneca
AZN
$251B
| $2.64K | ﹤0.01% |
+20
| New | +$2.73K |
|
322
Intuitive Surgical
ISRG
$139B
| $2.63K | ﹤0.01% |
+9
| New | +$2.81K |
|
323
Dominion Energy
D
$59.1B
| $2.59K | ﹤0.01% |
+58
| New | +$2.88K |
|
324
Invesco Senior Loan ETF
BKLN
$6.74B
| $2.48K | ﹤0.01% |
118
| – | – |
|
325
Vertex Pharmaceuticals
VRTX
$133B
| $2.43K | ﹤0.01% |
+7
| New | +$2.45K |
|
Similar funds
IECM
ERWM
CIG
JHCP
NPCM
TCM
OCAM
WAM
Perkins Coie Trust Company's Q3 2023 Portfolio in Review
As of Q3 2023, Perkins Coie Trust Company held 615 positions worth $354M, up 0.65% from $352M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Perkins Coie Trust Company deployed $18.8M of net new capital in Q3 2023, opening 388 new positions and adding to 118 existing holdings. Its largest new stake was iShares Biotechnology ETF: 20,476 shares worth $2.5M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P Biotech ETF, an estimated $2.95M trimmed.
- Perkins Coie Trust Company's largest Q3 2023 buy was iShares Biotechnology ETF: 20,476 shares worth $2.5M.
- Perkins Coie Trust Company added most to Boeing in Q3 2023, an estimated $8.91M increase.
- Perkins Coie Trust Company's biggest Q3 2023 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $2.95M.
- Perkins Coie Trust Company fully exited W.P. Carey in Q3 2023, selling an estimated $35.5K.
- Perkins Coie Trust Company's ten largest holdings make up 43% of its $354M portfolio in Q3 2023.
- Perkins Coie Trust Company opened 388 new positions and closed 9 in Q3 2023.
- Perkins Coie Trust Company's portfolio value rose 0.65% quarter-over-quarter to $354M.
Based on Perkins Coie Trust Company's 13F filing for Q3 2023, filed 11 Oct 2023.